Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-23-025388
Filing Date
2023-07-24
Accepted
2023-07-24 17:23:54
Documents
76

Document Format Files

Seq Description Document Type Size
1 forms-1a.htm   iXBRL S-1/A 1665746
2 forms-1a_001.jpg GRAPHIC 280479
3 aud_001.jpg GRAPHIC 2879
4 ex5-1.htm EX-5.1 16657
5 ex5-1_001.jpg GRAPHIC 2592
6 ex16-2.htm EX-16.2 8736
7 ex23-1.htm EX-23.1 7881
8 ex23-2.htm EX-23.2 1010
9 ex23-1_001.jpg GRAPHIC 5101
10 ex23-1_003.jpg GRAPHIC 1346
11 ex23-2_001.jpg GRAPHIC 176166
  Complete submission text file 0001493152-23-025388.txt   6811624

Data Files

Seq Description Document Type Size
12 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT impb-20230331.xsd EX-101.SCH 33454
13 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT impb-20230331_cal.xml EX-101.CAL 52813
14 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT impb-20230331_def.xml EX-101.DEF 190221
15 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT impb-20230331_lab.xml EX-101.LAB 268930
16 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT impb-20230331_pre.xml EX-101.PRE 233840
69 EXTRACTED XBRL INSTANCE DOCUMENT forms-1a_htm.xml XML 812552
Mailing Address 200 CANAL VIEW BLVD SUITE 104 ROCHESTER NY 14623
Business Address 200 CANAL VIEW BLVD SUITE 104 ROCHESTER NY 14623 585 232 1500
IMPACT BIOMEDICAL INC. (Filer) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-253037 | Film No.: 231105898
SIC: 2834 Pharmaceutical Preparations